Advertisement
Research Article

HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection

  • Aidan MacNamara,

    Affiliation: Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Aileen Rowan,

    Affiliation: Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Silva Hilburn,

    Affiliation: Section of Infectious Diseases, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Ulrich Kadolsky,

    Affiliation: Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Hiroshi Fujiwara,

    Affiliation: Department of Bioregulatory Medicine, Graduate School of Medicine, Ehime University, and Ehime University Proteomedicine Research Center, Toh-on city, Ehime, Japan

    X
  • Koichiro Suemori,

    Affiliation: Department of Bioregulatory Medicine, Graduate School of Medicine, Ehime University, and Ehime University Proteomedicine Research Center, Toh-on city, Ehime, Japan

    X
  • Masaki Yasukawa,

    Affiliation: Department of Bioregulatory Medicine, Graduate School of Medicine, Ehime University, and Ehime University Proteomedicine Research Center, Toh-on city, Ehime, Japan

    X
  • Graham Taylor,

    Affiliation: Section of Infectious Diseases, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Charles R. M. Bangham,

    Affiliation: Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Becca Asquith mail

    b.asquith@ic.ac.uk

    Affiliation: Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom

    X
  • Published: September 23, 2010
  • DOI: 10.1371/journal.ppat.1001117

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.